Tuesday, 22 March 2016

U-turn on NICE approval of prostate cancer drug

Abiraterone now approved for use in NHS in England and Wales

Related items from OnMedica

NICE makes U-turn in favour of abiraterone
Scientists find five different types of prostate cancer
Fewer but higher doses of radiotherapy good for prostate cancer
High hopes for targeted prostate cancer drug
Statins may slow prostate cancer progression in advanced disease
via OnMedica News Read More Here..

No comments:

Post a Comment